Dr Evans is responsible for formulating Clairvoyance corporate
strategy, business relations and new technology and product directions,
in addition to being the chief
executive officer of the corporation. Dr Evans also leads the
company's research activities and the development of new intellectual
property, having initiated and co-founded Clairvoyance (originally,
CLARITECH) Corporation in September 1992. Between September 1992
and August 1996, he served as the Chairman and Chief Scientist
and led the product-development and marketing efforts of the company.
Before joining Clairvoyance full-time as President, CEO, and Chief Scientist, in September 1996, Dr Evans was Professor of Linguistics and Computer Science, Carnegie Mellon University, with appointments in the Department of Philosophy and the Department of Computer Science. In addition to teaching and doing research at the university, he was the Director of the Laboratory for Computational Linguistics (LCL), which he founded in 1986, and Director of the academic Computational Linguistics Program, which he initiated in 1985.
Dr Evans began the CLARIT Project at CMU in 1988. The technology developed by the project (in the period between 1988 and 1992) provided the basis for the CLARIT system and Clairvoyance product development. While at CMU, Dr Evans was the principal or co-principal investigator on thirty-three funded research projects.
In the past eighteen years, Dr Evans has served as a consultant to academic, research, commercial and government groups, including the Center for Medical Education, McGill University; the National Library of Medicine; TNO Institute of Applied Physics (The Netherlands); Oregon Health Sciences University; Digital France; the National Technology Transfer Center; and various US government intelligence community organizations.
Dr Evans has authored three books, seventy-nine refereed publications,
and sixty-six technical reports. He has received fourteen patents;
six more are pending in the US. He is a Fellow of the American
College of Medical Informatics (ACMI).
dae@clairvoyancecorp.com